Urology

Surveillance and follow-up of early prostate cancer

Ahlberg, Mats Steinholtz

2024

• Download full text (pdf) of Surveillance and follow-up of early prostate cancer

Microwave ablation of 105 T1 renal tumors: technique efficacy with a mean follow-up of two years

Acosta Ruiz, Vanessa; Dahlman, Pär; Brekkan, Einar; Lönnemark, Maria et al.

Part of Acta Radiologica, p. 294-301, 2024

• DOI for Microwave ablation of 105 T1 renal tumors: technique efficacy with a mean follow-up of two years
• Download full text (pdf) of Microwave ablation of 105 T1 renal tumors: technique efficacy with a mean follow-up of two years

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Part of PLOS ONE, 2024

• DOI for Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Download full text (pdf) of Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial

Westerberg, Marcus; Holmberg, Lars; Ekbom, Anders; Metcalfe, Chris et al.

Part of Scandinavian Journal of Gastroenterology, p. 503-511, 2024

• DOI for The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial
• Download full text (pdf) of The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial

Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer

Thomsen, Frederik F.; Garmo, Hans; Egevad, Lars; Stattin, Pär et al.

Part of Scandinavian journal of urology, p. 76-83, 2024

• DOI for Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer
• Download full text (pdf) of Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer

Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts

Fritz, Josef; Jochems, Sylvia H. J.; Bjorge, Tone; Wood, Angela M. et al.

Part of British Journal of Cancer, p. 308-316, 2024

• DOI for Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts
• Download full text (pdf) of Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts

Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Stattin, Pär; Westerberg, Marcus; Lissbrant, Ingela Franck; Eriksson, Marie Hjälm et al.

Part of Clinical Genitourinary Cancer, p. 1070-107000000000, 2023

• DOI for Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden
• Download full text (pdf) of Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Westerberg, Marcus; Beckmann, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Part of Journal of Clinical Epidemiology, p. 22-30, 2023

• DOI for Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
• Download full text (pdf) of Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

How to model temporal changes in epidemiological data: Treatment trajectories in men with prostate cancer

Ventimiglia, Eugenio

2023

• Download full text (pdf) of How to model temporal changes in epidemiological data: Treatment trajectories in men with prostate cancer

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Mezheyeuski, Artur; Backman, Max; Mattsson, Johanna Sofia Margareta; Martin-Bernabe, Alfonso et al.

Part of EBioMedicine, 2023

• DOI for An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
• Download full text (pdf) of An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Short term outcomes after robot assisted and open cystectomy- A nation-wide population-based study

Bergengren, Oskar; Belozerov, Alexej; Bill-Axelson, Anna; Garmo, Hans et al.

Part of European Journal of Surgical Oncology, p. 868-874, 2023

• DOI for Short term outcomes after robot assisted and open cystectomy- A nation-wide population-based study
• Download full text (pdf) of Short term outcomes after robot assisted and open cystectomy- A nation-wide population-based study

Estimation in discrete time coarsened multivariate longitudinal models

Westerberg, Marcus

Part of Statistical Methods in Medical Research, p. 806-819, 2023

• DOI for Estimation in discrete time coarsened multivariate longitudinal models
• Download full text (pdf) of Estimation in discrete time coarsened multivariate longitudinal models

Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Lin, E.; Garmo, Hans; Hagström, Emil; Van Hemelrijck, Mieke et al.

Part of British Journal of Cancer, p. 814-824, 2023

• DOI for Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
• Download full text (pdf) of Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study

Sun, Ming; Fritz, Josef; Häggström, Christel; Bjørge, Tone et al.

Part of Journal of the National Cancer Institute, p. 456-467, 2023

• DOI for Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study
• Download full text (pdf) of Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study

Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study

Jochems, Sylvia H. J.; Fritz, Josef; Häggström, Christel; Jarvholm, Bengt et al.

Part of European Urology, p. 422-431, 2023

• DOI for Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study
• Download full text (pdf) of Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study

Endoscopist Characteristics and Polyp Detection in Colonoscopy: Cross-Sectional Analyses of Screening of Swedish Colons

Sekiguchi, Masau; Westerberg, Marcus; Ekbom, Anders; Hultcrantz, Rolf et al.

Part of Gastroenterology, p. 293-2950000, 2023

• DOI for Endoscopist Characteristics and Polyp Detection in Colonoscopy: Cross-Sectional Analyses of Screening of Swedish Colons

Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Part of JNCI CANCER SPECTRUM, 2023

• DOI for Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study
• Download full text (pdf) of Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study

2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review

Bergengren, Oskar; Pekala, Kelly R.; Matsoukas, Konstantina; Fainberg, Jonathan et al.

Part of European Urology, p. 191-206, 2023

• DOI for 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Kerzeli, Iliana Kyriaki; Kostakis, Alexandros; Türker, Polat; Malmström, Per-Uno et al.

Part of BMC Cancer, 2023

• DOI for Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
• Download full text (pdf) of Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade

Röbeck, Pontus; Franzén, Bo; Cantera-Ahlman, Rafaele; Dragomir, Anca et al.

Part of Cytopathology, p. 286-294, 2023

• DOI for Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade
• Download full text (pdf) of Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade

Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Wilberg Orrason, Andri; Styrke, Johan; Garmo, Hans; Stattin, Pär

Part of BJU International, p. 486-493, 2023

• DOI for Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden
• Download full text (pdf) of Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Part of European Urology, p. 263-272, 2023

• DOI for Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies

Feng, Shuo; Lin, E.; Cowling, Benjamin J.

Part of LANCET REGIONAL HEALTH-AMERICAS, 2023

• DOI for Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies
• Download full text (pdf) of Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies

P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer

Röbeck, Pontus; Xu, Lidi; Ahmed, Dilruba; Dragomir, Anca et al.

Part of The Prostate, p. 831-839, 2023

• DOI for P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer
• Download full text (pdf) of P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer

Design considerations for observational studies of drugs for advanced cancer

Garcia-Albeniz, Xabier; Stattin, Pär; Westerberg, Marcus; Weinrib, Rachel et al.

Part of Pharmacoepidemiology and Drug Safety, p. 812-815, 2023

• DOI for Design considerations for observational studies of drugs for advanced cancer
• Download full text (pdf) of Design considerations for observational studies of drugs for advanced cancer

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.

George, Gincy; Garmo, Hans; Adolfsson, Jan; Elf, Kristin et al.

Part of Journal of Oncology, p. 9527920, 2023

• DOI for Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Robinson, David; Abdulkareem, Rafid; Nasrollah, Delshad; Ljung, Anders et al.

Part of JAMA Network Open, 2023

• DOI for Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Corsini, Christian; Garmo, Hans; Wilberg Orrason, Andri; Gedeborg, Rolf et al.

Part of JAMA Network Open, 2023

• DOI for Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
• Download full text (pdf) of Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Ahlberg, Mats Steinholtz; Garmo, Hans; Holmberg, Lars; Bill-Axelson, Anna

Part of European Urology Open Science, p. 166-173, 2023

• DOI for Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes
• Download full text (pdf) of Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Active surveillance should be considered for select men with Grade Group 2 prostate cancer

Pekala, Kelly R.; Bergengren, Oskar; Eastham, James A.; Carlsson, Sigrid V.

Part of BMC Urology, 2023

• DOI for Active surveillance should be considered for select men with Grade Group 2 prostate cancer
• Download full text (pdf) of Active surveillance should be considered for select men with Grade Group 2 prostate cancer

Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study

Jochems, Sylvia H. J.; Fritz, Josef; Häggström, Christel; Stattin, Pär et al.

Part of Cancer Medicine, p. 13732-13744, 2023

• DOI for Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study
• Download full text (pdf) of Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study

Thanks and good bye Taylor & Francis, authors and readers see you at Scand J Urol's new website!

Stattin, Pär

Part of Scandinavian journal of urology, p. 1-1, 2023

• DOI for Thanks and good bye Taylor & Francis, authors and readers see you at Scand J Urol's new website!

Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Bonde, Tiago M.; Garmo, Hans; Stattin, Pär; Nilsson, Per et al.

Part of Acta Oncologica, p. 1815-1821, 2023

• DOI for Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
• Download full text (pdf) of Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.: -A Swedish nationwide cohort study from 1997 to 2019

Wang, Eugen Y-H; Hagberg, Oskar; Malmström, Per-Uno

Part of PLOS ONE, 2023

• DOI for The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.: -A Swedish nationwide cohort study from 1997 to 2019
• Download full text (pdf) of The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.: -A Swedish nationwide cohort study from 1997 to 2019

Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.

Shore, Richard; Zhang, Ji; Ye, Weimin; Stattin, Pär et al.

Part of Cancer Causes and Control, p. 949-961, 2023

• DOI for Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.
• Download full text (pdf) of Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.

Welcome to the new Scandinavian Journal of Urology!

Stattin, Pär

Part of Scandinavian journal of urology, 2023

• DOI for Welcome to the new Scandinavian Journal of Urology!
• Download full text (pdf) of Welcome to the new Scandinavian Journal of Urology!

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; Styrke, Johan et al.

Part of Scandinavian journal of urology, p. 93-100, 2023

• DOI for Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden
• Download full text (pdf) of Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up

Malmström, Per-Uno; Gårdmark, Truls

Part of Scandinavian journal of urology, p. 109-114, 2023

• DOI for Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up
• Download full text (pdf) of Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Watts, Eleanor L.; Perez-Cornago, Aurora; Fensom, Georgina K.; Smith-Byrne, Karl et al.

Part of International Journal of Epidemiology, p. 71-86, 2023

• DOI for Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
• Download full text (pdf) of Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Angiosarcoma in the breast: a population-based cohort from Sweden

Olander, Susanne; Wennstig, Anna-Karin; Garmo, Hans; Holmberg, Lars et al.

Part of British Journal of Surgery, p. 1850-1856, 2023

• DOI for Angiosarcoma in the breast: a population-based cohort from Sweden

Re: An Integrated Multi-Omics Analysis Identifies Prognostic Molecular Subtypes of Non-Muscle Invasive Bladder Cancer: Editorial Comment

Lindskrog, S. , V; Prip, F.; Lamy, P.; Taber, A. et al.

Part of Journal of Urology, p. 733-733, 2022

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Gedeborg, Rolf; Lindhagen, Lars; Loeb, Stacy; Styrke, Johan et al.

Part of Scandinavian journal of urology, p. 104-111, 2022

• DOI for Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer
• Download full text (pdf) of Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality

Söderdahl, Fabian; Xu, Li-Di; Bring, Johan; Häggman, Michael

Part of Research and Reports in Urology, p. 203-217, 2022

• DOI for A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality
• Download full text (pdf) of A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality

Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study

Jochems, Sylvia H. J.; Häggström, Christel; Stattin, Pär; Järvholm, Bengt et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 1483-1491, 2022

• DOI for Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study

Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths

Lycken, Magdalena; Bergengren, Oskar; Drevin, Linda; Garmo, Hans et al.

Part of European Urology Open Science, p. 81-87, 2022

• DOI for Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths
• Download full text (pdf) of Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Bonde, Tiago M.; Westerberg, Marcus; Aly, Markus; Eklund, Martin et al.

Part of Scandinavian journal of urology, p. 169-175, 2022

• DOI for Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
• Download full text (pdf) of Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; Fallara, Giuseppe et al.

Part of Acta Oncologica, p. 328-332, 2022

• DOI for Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records

Alverbratt, Charlotte; Vikman, Hanna; Eriksson, Marie Hjalm; Stattin, Pär et al.

Part of Scandinavian journal of urology, p. 95-101, 2022

• DOI for Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records
• Download full text (pdf) of Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records

Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumors

Häggman, Michael; Dahlman, Par; Ahlberg, Mats; Liss, Per et al.

Part of Acta Radiologica Open, 2022

• DOI for Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumors
• Download full text (pdf) of Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumors

Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study

Braide, Karin; Kindblom, Jon; Karlsson, Camilla Thellenberg; Stattin, Pär et al.

Part of BJU International, p. 799-808, 2022

• DOI for Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study